Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
02
2018
accepted:
05
12
2018
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
26
9
2019
Statut:
epublish
Résumé
South Africa has the highest tuberculosis (TB) disease incidence rate in the world, and TB is the leading infectious cause of death. Decisions on, and funding for, TB prevention and care policies are decentralised to the provincial governments and therefore, tools to inform policy need to operate at this level. We describe the use of a mathematical model planning tool at provincial level in a high HIV and TB burden country, to estimate the impact on TB burden of achieving the 90-(90)-90 targets of the Stop TB Partnership Global Plan to End TB. "TIME Impact" is a freely available, user-friendly TB modelling tool. In collaboration with provincial TB programme staff, and the South African National TB Programme, models for three (of nine) provinces were calibrated to TB notifications, incidence, and screening data. Reported levels of TB programme activities were used as baseline inputs into the models, which were used to estimate the impact of scale-up of interventions focusing on screening, linkage to care and treatment success. All baseline models predicted a trend of decreasing TB incidence and mortality, consistent with recent data from South Africa. The projected impacts of the interventions differed by province and were greatly influenced by assumed current coverage levels. The absence of provincial TB burden estimates and uncertainty in current activity coverage levels were key data gaps. A user-friendly modelling tool allows TB burden and intervention impact projection at the sub-national level. Key sub-national data gaps should be addressed to improve the quality of sub-national model predictions.
Identifiants
pubmed: 30682028
doi: 10.1371/journal.pone.0209320
pii: PONE-D-18-03621
pmc: PMC6347133
doi:
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0209320Subventions
Organisme : Medical Research Council
ID : MR/P002404/1
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Bull World Health Organ. 2014 Feb 1;92(2):126-38
pubmed: 24623906
Lancet Infect Dis. 2015 Sep;15(9):1066-1076
pubmed: 26112077
BMC Med. 2016 Mar 24;14:56
pubmed: 27012808
Lancet Glob Health. 2016 Nov;4(11):e816-e826
pubmed: 27720689
PLoS One. 2015 May 04;10(5):e0126267
pubmed: 25938501
Epidemics. 2016 Mar;14:54-61
pubmed: 26972514
Lancet Glob Health. 2016 Nov;4(11):e806-e815
pubmed: 27720688
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11293-8
pubmed: 18695217
Lancet. 1999 Feb 6;353(9151):444-9
pubmed: 9989714
AIDS. 2014 Jan;28 Suppl 1:S25-34
pubmed: 24468944
PLoS One. 2015 Apr 07;10(4):e0122514
pubmed: 25849558
Int J Tuberc Lung Dis. 2018 Jun 1;22(6):606-613
pubmed: 29862943
Lancet Glob Health. 2015 Aug;3(8):e450-e457
pubmed: 26187490